Overview

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

Status:
Completed
Trial end date:
2019-08-02
Target enrollment:
Participant gender:
Summary
In the present study, the rate and extent of hCG absorption will be compared between the two treatments in healthy women aged 20 to 45 years.
Phase:
Phase 1
Details
Lead Sponsor:
IBSA Institut Biochimique SA
Treatments:
Chorionic Gonadotropin